6 hours Wall Street Analysts Think ARS Pharmaceuticals, Inc. (SPRY) Could Surge 67.56%: Read This Before Placing a BetZacks

The average of price targets set by Wall Street analysts indicates a potential upside of 67.6% in ARS Pharmaceuticals, Inc. (SPRY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Pharmaceuticals · Wall Street

1 hour Ionis Pharmaceuticals, Inc. (IONS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

2 hours Wall Street Lunch: Trump Trade In Full EffectSeeking Alpha X

3 hours Why Wall Street Got Robinhood’s Earnings All WrongThe Motley Fool X

3 hours 1 Incredible Growth Stock to Buy Before It Climbs 55% Over the Next 12 Months, According to Wall Street AnalystsThe Motley Fool X

3 hours Wall Street rallies to record high as Trump returns as US presidentInvesting.com X

3 hours I’ve been maxing out my retirement accounts – but is it actually hurting my early retirement goals?24/7 Wall St. X

4 hours I am looking to buy a $4 million house and have enough cash to buy it – should I use the cash or get a loan?24/7 Wall St. X

4 hours Is Altria Stock Going to $60? 1 Wall Street Analyst Thinks So.The Motley Fool X

4 hours Home to Some of the Largest American Military Bases, This State Is Critical to US Defense Operations24/7 Wall St. X

4 hours Analysts Abandon Super Micro After Negative Quarterly UpdateInvestor's Business Daily X

4 hours The Fed Will Probably Cut Interest Rates Again This Week. But by How Much?Money.com X

5 hours Tesla’s stock is soaring on Trump’s win. Here’s why Wall Street is so upbeat.MarketWatch X

6 hours Stocks roar out of the gate after Donald Trump election winCBS News X

6 hours Analysts Estimate Everi Holdings (EVRI) to Report a Decline in Earnings: What to Look Out forZacks X

6 hours AFC Gamma Inc. (AFCG) Expected to Beat Earnings Estimates: Should You Buy?Zacks X

6 hours Will NextNav Inc. (NN) Report Negative Earnings Next Week? What You Should KnowZacks X

6 hours Helmerich & Payne (HP) Reports Next Week: Wall Street Expects Earnings GrowthZacks X

6 hours Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks X

6 hours Geopark (GPRK) to Report Q3 Results: Wall Street Expects Earnings GrowthZacks X

6 hours Does Sun Country Airlines (SNCY) Have the Potential to Rally 25.36% as Wall Street Analysts Expect?Zacks X

6 hours Wall Street Analysts Predict a 73.42% Upside in Controladora Vuela (VLRS): Here’s What You Should KnowZacks X

6 hours Wall Street Analysts Predict a 25.09% Upside in Weave Communications (WEAV): Here’s What You Should KnowZacks X

6 hours Wall Street Analysts Predict a 33.29% Upside in Sunrun (RUN): Here’s What You Should KnowZacks X

6 hours Can Orion Marine (ORN) Climb 54.36% to Reach the Level Wall Street Analysts Expect?Zacks X

6 hours Wall Street Analysts See a 134.17% Upside in BlackSky Technology (BKSY): Can the Stock Really Move This High?Zacks X

6 hours Wall Street Analysts Predict a 106.45% Upside in Profound Medical (PROF): Here’s What You Should KnowZacks X

6 hours Wall Street Analysts See a 136.83% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?Zacks X

6 hours Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?Zacks X

6 hours Dividend King Lowe’s Just Paid Investors: Here’s How Much They Got24/7 Wall St. X

6 hours Wall Street Reacts: It’s Full Risk-On as Trump Scores WinYahoo Finance X

7 hours Artificial Intelligence Will Be Key Focus Area For President-Elect TrumpInvestor's Business Daily X

7 hours 2 of the Highest-Yielding Dividend Kings Are Our Top November Picks24/7 Wall St. X

7 hours Wall Street scores political victory with a Trump win: ‘This should aid all banks’Yahoo Finance X

9 hours Wall Street Breakfast Podcast: Trump Wins Presidential ElectionSeeking Alpha X

9 hours Nvidia Tops Apple as Most Valuable Company24/7 Wall St. X

9 hours Analysis-Wall Street girds for Trump 2.0: Tariffs, tax cuts and volatilityYahoo Finance X

9 hours Apple Warns on Product Profit24/7 Wall St. X

10 hours Donald Trump Is the President-Elect — but There’s an Even Bigger Winner TodayThe Motley Fool X

10 hours This Under-the-Radar Industrial Stock is Actually A Stealth Artificial Intelligence (AI) PlayThe Motley Fool X

11 hours Should You Buy Palantir Stock After Its 170% Gain in 2024? Wall Street Has a Clear Answer for InvestorsThe Motley Fool X

11 hours Warren Buffett’s $166 Billion Warning to Wall Street Has Become DeafeningThe Motley Fool X

11 hours This Ultra-High-Yield Stock Is Dirt Cheap — and Wall Street Thinks It Will Soar 32% Over the Next 12 MonthsThe Motley Fool X

12 hours Is It Time to Buy October’s Worst-Performing Nasdaq Stocks?The Motley Fool X

12 hours Billionaire Cliff Asness Sold 92% of AQR’s Stake in Taiwan Semiconductor and Is Piling Into This Scorching-Hot Ultra-High-Yield Dividend StockThe Motley Fool X

12 hours Warren Buffett Just Sent Wall Street a Historic $127 Billion Warning. History Says the Stock Market Will Do This Next.The Motley Fool X

13 hours Republicans Reclaim the Senate Majority: Here’s What History Says Happens to Stocks When the GOP Controls the Upper House of CongressThe Motley Fool X

17 hours Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2024 Earnings Call TranscriptSeeking Alpha X

17 hours Wall Street Rallies on Election Day Indicating Strong EconomyInc.com X

19 hours Syndax Pharmaceuticals, Inc. (SNDX) Q3 2024 Earnings Call TranscriptSeeking Alpha X

19 hours Rhythm Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X